HomeCompareLIOPY vs JNJ

LIOPY vs JNJ: Dividend Comparison 2026

LIOPY yields 1.43% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LIOPY wins by $9.8K in total portfolio value
10 years
LIOPY
LIOPY
● Live price
1.43%
Share price
$16.40
Annual div
$0.23
5Y div CAGR
38.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.2K
Annual income
$6,267.32
Full LIOPY calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — LIOPY vs JNJ

📍 LIOPY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLIOPYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LIOPY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LIOPY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LIOPY
Annual income on $10K today (after 15% tax)
$121.42/yr
After 10yr DRIP, annual income (after tax)
$5,327.22/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, LIOPY beats the other by $1,289.82/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LIOPY + JNJ for your $10,000?

LIOPY: 50%JNJ: 50%
100% JNJ50/50100% LIOPY
Portfolio after 10yr
$35.3K
Annual income
$5,508.60/yr
Blended yield
15.59%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LIOPY
No analyst data
Altman Z
3.1
Piotroski
8/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LIOPY buys
0
JNJ buys
0
No recent congressional trades found for LIOPY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLIOPYJNJ
Forward yield1.43%2.14%
Annual dividend / share$0.23$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR38.2%28%
Portfolio after 10y$40.2K$30.5K
Annual income after 10y$6,267.32$4,749.88
Total dividends collected$17.9K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LIOPY vs JNJ ($10,000, DRIP)

YearLIOPY PortfolioLIOPY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,897$197.41$10,594$274.49+$303.00LIOPY
2$11,938$277.85$11,294$360.69+$644.00LIOPY
3$13,167$393.14$12,133$476.91+$1.0KLIOPY
4$14,649$560.04$13,156$635.42+$1.5KLIOPY
5$16,479$804.74$14,432$854.61+$2.0KLIOPY
6$18,802$1,169.25$16,056$1,162.76+$2.7KLIOPY
7$21,841$1,723.06$18,175$1,604.53+$3.7KLIOPY
8$25,955$2,585.22$21,009$2,252.68+$4.9KLIOPY
9$31,740$3,968.01$24,911$3,229.73+$6.8KLIOPY
10$40,229$6,267.32$30,458$4,749.88+$9.8KLIOPY

LIOPY vs JNJ: Complete Analysis 2026

LIOPYStock

Lion Corporation manufactures and sells consumer and industrial products in Japan and internationally. It operates through three segments: Consumer Products Business, Industrial Products Business, and Overseas Business. The company offers dental and oral care products, including toothpastes, toothbrushes, dental floss, dental rinses, mouthwashes and breath fresheners, periodontitis ointments, and denture products; body care products, such as shampoos and conditioners, hand soaps, sanitizers, wet wipes, body washes, skin and acne care products, antiperspirants and deodorants, hair-nourishment treatments, men's care and toiletries products, and foot care products. It also provides antipyretic analgesics, eye drops and eye care products, cold medicines, gargles, cold relief products, topical anti-inflammatory analgesics, antidiarrheal and gastrointestinal medicines, health tonic drinks and vitamin supplements, acne and anti-drowsiness medicines, and dermatologic agents. In addition, the company offers fabric care products, such as laundry detergent, delicate detergent, prewash treatment, stain remover, bleach, and fabric softener; clothing care products; household cleaners; kitchen cleanup products comprises dishwashing detergents and antibacterial and deodorizing products; and food preparation products. Further, it provides health and beauty food products consisting of supplements and health tonic drinks; specialty chemicals, and chemical products, include rubber processing and additive agents, mandrel release agents, fatty acid methyl esters, plant-based electrical insulating oils, concrete admixtures, ground improvement and asphalt recycling agents, surfactants, and cosmetics ingredients, as well as electro-conductive carbon black and pressure-sensitive adhesives; pet supplies; and gift and special order products. The company was founded in 1891 and is headquartered in Tokyo, Japan.

Full LIOPY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this LIOPY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LIOPY vs SCHDLIOPY vs JEPILIOPY vs OLIOPY vs KOLIOPY vs MAINLIOPY vs ABBVLIOPY vs MRKLIOPY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.